Jozefien Declercq

TIM3+<i> TRBV11-2</i> T cells and IFNγ signature in patrolling monocytes and CD16+ NK cells delineate MIS-C

Levi Hoste, Lisa Roels, Leslie Naesens et al. · The Journal of Experimental Medicine · 2021 · 84 citations · Full text

Multisystem Inflammatory Syndrome, Adaptive Immune System, Cd16+ Nk Cells +22

Case Report: Convalescent Plasma, a Targeted Therapy for Patients with CVID and Severe COVID-19

Karel Van Damme, Simon J. Tavernier, Nele Van Roy et al. · Frontiers in Immunology · 2020 · 51 citations · Full text

Long Covid, Viral Persistence, Prolonged Viral Shedding +14

Loss of GM-CSF-dependent instruction of alveolar macrophages in COVID-19 provides a rationale for inhaled GM-CSF treatment

Cédric Bosteels, Karel Van Damme, Elisabeth De Leeuw et al. · Cell Reports Medicine · 2022 · 43 citations · Full text

Efficacy and safety of the investigational complement C5 inhibitor zilucoplan in patients hospitalized with COVID-19: an open-label randomized controlled trial

Elisabeth De Leeuw, Karel Van Damme, Jozefien Declercq et al. · Respiratory Research · 2022 · 22 citations · Full text

Granulocyte-colony stimulating factor: Missing link for stratification of type 2–high and type 2–low chronic rhinosinusitis patients

Sharon Van Nevel, Jozefien Declercq, Gabriële Holtappels et al. · Journal of Allergy and Clinical Immunology · 2022 · 19 citations · Full text

Inflammation, Clinical Immunology, Allergy +8